Top Markets
#1 Siacoin Siacoin +52.09%
#2 Official Trump Official Trump +35.11%
#3 Melania Meme Melania Meme +22.79%
#4 Nockchain Nockchain +21.64%
#5 EXOD EXOD +18.93%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +18.88%
#7 MowCat MowCat +18.80%
#8 Mubarak Mubarak +17.99%
#9 Unit Pump Unit Pump +15.74%
#10 Pump.fun Pump.fun +15.74%
Coin of the day
Siacoin Siacoin
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Pozycja w akcjach #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Cena akcji
$0.17616661
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$73.48M
Zmiana (1 dzień)
0.18%
Zmiana (1 rok)
-37.76%
Kraj
TW
Handel Mercury Biopharmaceutical Corporation (6932)

Kategoria

Healthcare
EPS dla Mercury Biopharmaceutical Corporation (6932)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy Mercury Biopharmaceutical Corporation, obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla Mercury Biopharmaceutical Corporation od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $0.56 -
IN